NVP-BSK805 2HCl,
NVP-BSK805 dihydrochloride,
1092499-93-8,
NVP-BSK805 (dihydrochloride),
1942919-79-0,
NVPBSK805,
8-(3,5-DIFLUORO-4-(MORPHOLINOMETHYL)PHENYL)-2-(1-(PIPERIDIN-4-YL)-1H-PYRAZOL-4-YL)QUINOXALINE DIHYDROCHLORIDE,
1092499-93-8 (free base),
NVP-BSK805.2HCl,
cc-625,
NVP-GSK 805,
C27H28F2N6O.2ClH,
C27H28F2N6O.2HCl,
DTXSID20720930,
NVP-BSK805/NVPBSK805,
SYN1136,
BCP23423,
2606AH,
HY-14722A,
s2686,
AKOS028109721,
BCP9001012,
CS-2287,
4CA-0324,
AS-16275,
DA-47942,
BCP0726000306,
FT-0726394,
SW219437-1,
1092499-93-8 pound not NVP BSK805,
J-002254,
8-(3,5-difluoro-4-(morpholinomethyl)phenyl)-2-(1-(piperidin-4-yl)-1H-pyrazol-4-yl)quinoxaline dihydr,
8-[3,5-Difluoro-4-(4-morpholinylmethyl)phenyl]-2-[1-(4-piperidinyl)-1H-pyrazol-4-yl]quinoxaline dihydrochloride,
8-[3,5-difluoro-4-(morpholin-4-ylmethyl)phenyl]-2-[1-(piperidin-4-yl)pyrazol-4-yl]quinoxaline dihydrochloride,
8-{3,5-Difluoro-4-[(morpholin-4-yl)methyl]phenyl}-2-[1-(piperidin-4-yl)-1H-pyrazol-4-yl]quinoxaline--hydrogen chloride (1/2),
NVP-BSK805,
BSK805,
A4148,
A11193,